Skip to product information

Lung Cancer Screening

Lung Cancer Screening

Regular price $2,688.00
Regular price Sale price $2,688.00
Save Sold out
10 People are looking at this
View full details
Selected Variant Image
Lung Cancer Screening
Regular price $2,688.00
Regular price Sale price $2,688.00
Selected Variant Image
Lung Cancer Screening
Regular price $2,688.00
Regular price Sale price $2,688.00
  • Description

  • Why Us?

Lung cancer is the leading cause of cancer deaths worldwide.
People who smoke have the greatest risk of lung cancer, though lung cancer can also occur in people who have never smoked. Lung cancer typically doesn't cause signs and symptoms in its earliest stages. Signs and symptoms of lung cancer typically occur when the disease is advanced.

Signs and symptoms of lung cancer may include:

  • A new cough that doesn't go away
  • Coughing up blood, even a small amount
  • Shortness of breath
  • Chest pain
  • Hoarseness
  • Losing weight without trying
  • Bone pain
  • Headache

Because CT scans are able to detect even very small nodules in the lungs, LDCT of the chest is especially effective for diagnosing lung cancer at its earliest, most treatable stage. Lung cancer screening with LDCT has been proven to reduce the number of deaths from lung cancer in patients at high risk.

Purchase Remarks: Doctors to conduct health consultation, physical examination and result report interpretation.

Doctor Consultation
- Detailed Medical History
- Physical Examination

Medical Imaging Examination :
 - Low Dose CT (Lung)

Clearbridge Health Limited is an integrated healthcare group with a focus on the delivery of precision medicine with businesses comprising of laboratory testing services, medical centres/clinics and strategic equity participation in complementary precision medical technology companies. We are present in more than 10 countries around the world and have plans to further expand our presence in Pan Asia. Working closely with healthcare professionals and globally-accredited laboratories, Clearbridge Health offers patient care through precision diagnostics, empowers clinicians and healthcare professionals to make reliable and accurate diagnoses, providing fresh insights into disease management, customising prevention and treatment programmes that are personalised and timely. Listed on the Catalist Board of the SGX-ST, Clearbridge Health Limited Group of Companies continues to provide effective ways to detect cancer, critical illness, and other lifestyle diseases in the world today.

VISION
Redefining healthcare in Asia with precision.
Empowering patient care with clarity.

MISSION
Setting a new standard for personalized care through the integration of healthcare services, medical technology and data science.

CORE VALUES
Kindness You always come first
Confidence We believe that better outcomes start with precise insights
Dependability Our people – they are our edge
Respect Professionalism in every circumstance
Trust Delivering healthcare services with utmost integrity